You are an industrial
hygienist for a major pharmaceutical company. The CEO has contacted you
regarding a new product line that will be produced in your facility. The new
product involves the handling and use of an engineered nanomaterial. To date,
your company’s health and safety program has not had to address any safety
concerns associated with handling and use of these materials. Using the Centers
for Disease Control document in the Unit VIII Required Reading section as your
authoritative source, prepare a three- to five-page “white paper”
that provides an overview of engineered materials and includes a discussion of
the following:
background and industry overview of engineered
nanomaterials,·
exposure control strategies,·
nanotechnology processes and engineering
controls,·
hazard control evaluations,·
health hazards associated with exposures, and·
conclusions and recommendations·
